1. HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair.
   Xing Guo et al, 2018, J Exp Clin Cancer Res CrossRef
2. The Anticancer Properties of Cordycepin and Their Underlying Mechanisms.
   So Young Yoon et al, 2018, Int J Mol Sci CrossRef
3. High-mobility group box 1 is a promising diagnostic and therapeutic monitoring biomarker in Cancers: A review
   Seidu A. Richard, 2018 CrossRef
4. Cordycepin Suppresses Endothelial Cell Proliferation, Migration, Angiogenesis, and Tumor Growth by Regulating Focal Adhesion Kinase and p53
   Yi-Ting Lin et al, 2019, Cancers CrossRef
5. Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity
   Shu-Man Liang et al, 2017, Sci Rep CrossRef
6. Therapeutic Potential and Biological Applications of Cordycepin and Metabolic Mechanisms in Cordycepin-Producing Fungi
   Peng Qin et al, 2019, Molecules CrossRef
7. Dual Regulation of L-Selectin-Mediated Leukocyte Adhesion by Endothelial Surface Glycocalyx
   Matthew A. Dragovich et al, 2017, Cel. Mol. Bioeng. CrossRef
8. Cordycepin in Anticancer Research: Molecular Mechanism of Therapeutic Effects.
   Md Asaduzzaman Khan et al, 2020, Curr Med Chem CrossRef
9. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
   Shunling Yuan et al, 2020, J Hematol Oncol CrossRef
10. Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma.
    Alessandro Allegra, 0 CrossRef
11. A Systematic Review of the Biological Effects of Cordycepin.
    Masar Radhi et al, 2021, Molecules CrossRef
12. Pharmacological and therapeutic potentials of cordycepin in hematological malignancies
    Zahra Taghinejad et al, 2023, Biochemical and Biophysical Research Communications CrossRef